In patients with low and high LC3 expression in tumors, the 1‐, 3‐, 5‐ and 7‐year HCC recurrence rates were 15.6%, 39.2%, 73.3% and 94.9% and 8.4%, 26.7%, 37.9% and 69.5%, respectively (Figure 1B). The gene discussed is MAP1LC3A; the disease is hepatocellular carcinoma.